CARE Ratings Ltd
CARE Ratings Q1 FY25 earnings call: Revenue & Margins
Q1 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on CARE Ratings Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Consolidated Revenue from Operations (Q1 FY25): Rs. Standalone Q1 FY25: - EBITDA: Rs.
From CARE Ratings Ltd's Q1 FY25 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated Revenue from Operations (Q1 FY25): Rs. 78.92 Crs, up 19% YoY (Page 13)
- Standalone Revenue from Operations (Q1 FY25): Rs. 65.34 Crs, up 16% YoY (Page 12)
- Segmental Contribution:
- Ratings Business: Rs. 70.65 Crs, up 19% YoY
- Non-Ratings Business: Rs. 8.27 Crs, up 31% YoY (Page 14)
- Profit After Tax (Consolidated): Rs. 21.38 Crs, up 16% YoY (Page 13)
- Profit After Tax (Standalone): Rs. 24.01 Crs, up 11% YoY (Page 12)
2 more points management made on revenue & sales performance
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings Ltd's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- ICRA Ltd (Q1 FY25)
Total revenue for Q1 FY2025 was ₹114.8 crore, up from ₹102.7 crore in Q1 FY2024, reflecting a growth of approximately 11.8%. Key concall takeaways from ICRA…
- IIFL Capital Services Ltd (Q1 FY25)
Q1 FY25 Revenue from Operations: ₹6,399 Mn, up 56% YoY from ₹4,091 Mn in Q1 FY24 (Page 20). Key concall takeaways from IIFL Capital Services Ltd's Q1 FY25…
- Geojit Financial Services Ltd (Q1 FY25)
Market Capitalization as on 30 June 2024: ₹2486 crore . Key concall takeaways from Geojit Financial Services Ltd's Q1 FY25 earnings call — and how it ranks…
Frequently Asked Questions
What were CARE Ratings Ltd Q1 FY25 results?
Consolidated Revenue from Operations (Q1 FY25): Rs. Standalone Q1 FY25: - EBITDA: Rs.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
The investor presentation does not mention any capex, capacity expansion, new plant, or project details including amounts, status, or timelines.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.